the company has always attached importance to the product, technology and R&D of process and treated R&D capacity strategically. The company established MEDISAN drug research institute and set MEDISAN pharmaceutical engineering technical research center, Beijing MEDISAN Technology and Xundao Technology, etc. so that the company’s internal R&D resources were organized inorganically and innovation efficiency was improved.

the company built a perfect innovation system and form gradually innovative corporate culture. With strong innovative capacity, the company has gradually improved innovative capacity and realized multiple innovation transformation achievements by combining independent and cooperative innovation and introducing innovation. The company has already been evaluated as provincial and municipal advantageous innovation patent model enterprise, provincial and municipal enterprise technical center, engineering technical research center in Heilongjiang province, provincial key laboratory, advanced unit with transformation and industrialization of scientific achievements and advanced collective with university-industry-research cooperation and “national scientific research workstations for postdoctors”. in the meantime, the company adopted multiple measures to guarantee the sustainable development of innovative capacity.

In order to promote the innovation and development of enterprise, and make full use of pharmaceutical resources and advanced research and development capabilities of institutions of higher education, the company reinforces cooperation and communication with other pharmaceutical industry enterprises and a number of institutions of higher education, builds a innovation system of university-industry collaboration, to form a virtuous circle of driving the development of medical industry with research & development, and promoting research & development with industrial capital.